Literature DB >> 22739695

Seroepidemiology of polioviruses among university students in northern Italy.

Vincenzo Baldo1, Tatjana Baldovin, Silvia Cocchio, Roberta Lazzari, Elena Saracino, Chiara Bertoncello, Alessandra Buja, Andrea Trevisan.   

Abstract

The widespread use of poliovirus vaccination schemes has led to a marked decline in the incidence of paralytic poliomyelitis worldwide, but wild poliovirus is still endemic in some developing countries, and in 2009 a total of 23 countries reported at least 1 case of poliomyelitis caused by wild-strain polio viruses. A serological survey was thus conducted on the immunological status against polioviruses of 318 young adults, classified by their country of origin. Immunity to poliomyelitis was assessed by neutralizing antibody titration in tissues cultured on microplates. The rate of seronegativity (≤ 1:8) in the study population was 26.7% for poliovirus type 1, 7.2% for type 2, and 22.6% for type 3. In our sample of 318 individuals, 219 (68.9%) were Italian and 99 (31.1%) were from outside the European Union (EU). The proportion of cases found seropositive to polioviruses 1 and 3 decreased significantly with older age; this age-related decrease was more evident in the Italian group than among the non-EU subjects. Any risk of the wild virus recurring and causing paralytic poliomyelitis must be prevented, keeping Europe polio free by means of appropriate immunological protection, until polio has been conclusively eradicated all over the world. Judging from our findings, it may be worth considering administering a fifth dose of polio vaccine to adolescents.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22739695      PMCID: PMC3416076          DOI: 10.1128/CVI.00054-12

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  14 in total

1.  Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.

Authors:  T M Herremans; J H Reimerink; A M Buisman; T G Kimman; M P Koopmans
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

2.  A seroprevalence study of poliovirus antibody in the population of northern Greece.

Authors:  F Frantzidou; E Diza; D Halkia; A Antoniadis
Journal:  Clin Microbiol Infect       Date:  2005-01       Impact factor: 8.067

3.  Seroprevalence of antibodies to poliovirus in individuals living in Portugal, 2002.

Authors:  M Pires de Miranda; M Carmo Gomes; H Rebelo de Andrade
Journal:  Euro Surveill       Date:  2007-06-01

4.  Immunity status against poliomyelitis in persons 13-14 years old living in Rome.

Authors:  I Mastroeni; A M Patti; A Fabrizi; A L Santi; A M Manduca; N Vescia; S Squarcione; G M Fara
Journal:  Vaccine       Date:  1997 Apr-May       Impact factor: 3.641

5.  Prevalence of antibody to poliovirus in England and Wales 1984-6.

Authors:  P M White; J Green
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-01

6.  Immunity to poliovirus among children and the elderly in north-east Italy.

Authors:  S Majori; V Baldo; A Poli; M Riolfatti; F Alborino; C Bonello; S Frau; T Baldovin; A Dal Zotto; G Romano; R Trivello
Journal:  J Prev Med Hyg       Date:  2006-03

7.  Immunity status to polioviruses among non-European union immigrants in Veneto Region (North-East Italy).

Authors:  R Trivello; T Ngatchu; V Marin; G Moretti; R Malatesta; P Maini; M E Moschen; V Baldo; L De Marzi; S Majori; A Puppo; G Renzulli
Journal:  Ann Clin Lab Sci       Date:  1996 Mar-Apr       Impact factor: 1.256

8.  Deficiency of immunity to poliovirus type 3: a lurking danger?

Authors:  Claudia Reinheimer; Imke Friedrichs; Holger F Rabenau; Hans W Doerr
Journal:  BMC Infect Dis       Date:  2012-01-26       Impact factor: 3.090

9.  Immunity status against poliomyelitis in Germany: determination of cut-off values in International Units.

Authors:  Sabine Diedrich; Hermann Claus; Eckart Schreier
Journal:  BMC Infect Dis       Date:  2002-02-06       Impact factor: 3.090

View more
  7 in total

Review 1.  Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type B vaccine; Infanrix™ hexa: twelve years of experience in Italy.

Authors:  Vincenzo Baldo; Paolo Bonanni; Marcela Castro; Giovanni Gabutti; Elisabetta Franco; Federico Marchetti; Rosa Prato; Francesco Vitale
Journal:  Hum Vaccin Immunother       Date:  2013-09-04       Impact factor: 3.452

2.  Assessment of seroprevalence against poliovirus among Italian adolescents and adults.

Authors:  Silvia Lupi; Armando Stefanati; Tatjana Baldovin; Alberto Roman; Vincenzo Baldo; Giovanni Gabutti
Journal:  Hum Vaccin Immunother       Date:  2018-12-20       Impact factor: 3.452

3.  PREVALENCE OF NEUTRALIZING ANTIBODIES AGAINST POLIOVIRUS 1, 2, AND 3 IN HEALTHCARE PROFESSIONALS AGED 20-50 YEARS.

Authors:  José Cassio de Moraes; Maria Josefa Penon Rujula; Marcelo Otsuka
Journal:  Rev Paul Pediatr       Date:  2021-02-03

4.  Immunogenicity of Viral Vaccines in the Italian Military.

Authors:  Claudia Ferlito; Roberto Biselli; Vincenzo Visco; Maria Sofia Cattaruzza; Maria Rosaria Capobianchi; Concetta Castilletti; Daniele Lapa; Loredana Nicoletti; Antonella Marchi; Fabio Magurano; Anna Rita Ciccaglione; Paola Chionne; Elisabetta Madonna; Isabella Donatelli; Laura Calzoletti; Concetta Fabiani; Michela Ileen Biondo; Raffaela Teloni; Sabrina Mariotti; Gerardo Salerno; Andrea Picchianti-Diamanti; Simonetta Salemi; Sara Caporuscio; Alberto Autore; Patrizia Lulli; Francesco Borelli; Marco Lastilla; Roberto Nisini; Raffaele D'Amelio
Journal:  Biomedicines       Date:  2021-01-17

5.  Long-Term Immunogenicity of Inactivated and Oral Polio Vaccines: An Italian Retrospective Cohort Study.

Authors:  Angela Maria Vittoria Larocca; Francesco Paolo Bianchi; Anna Bozzi; Silvio Tafuri; Pasquale Stefanizzi; Cinzia Annatea Germinario
Journal:  Vaccines (Basel)       Date:  2022-08-17

6.  [Investigation and response to an outbreak of wild poliovirus in Kinshasa].

Authors:  Muriel Nzazi Nsambu; Léodegal Bazira; Tiekoura Coulibaly; Albert Mbule; Michèle Dramaix Wilmet; Joris Losimba Likwela
Journal:  Pan Afr Med J       Date:  2013-05-31

7.  Is Italian population protected from Poliovirus? Results of a seroprevalence survey in Florence, Italy.

Authors:  Giovanni M Giammanco; Angela Bechini; Noemi Urone; Floriana Bonura; Sara Li Muli; Simona De Grazia; Irene Bellini; Emilia Tiscione; Sara Boccalini; Antonino Nastasi
Journal:  Hum Vaccin Immunother       Date:  2018-06-21       Impact factor: 3.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.